AKT1 and head and neck squamous cell carcinoma: Further, identification of pharmacologically safe chemopreventive agents that can suppress ST/nicotine induced PI3K/Akt pathway in HNSCC is likely to have the potential to prevent ST induced head and neck carcinogenesis.